Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety.
Saved in:
| Title: | Cefiderocol, a New Siderophore Cephalosporin for the Treatment of Complicated Urinary Tract Infections Caused by Multidrug-Resistant Pathogens: Preclinical and Clinical Pharmacokinetics, Pharmacodynamics, Efficacy and Safety. |
|---|---|
| Authors: | Lee, Young Ran1 (AUTHOR) young.lee@ttuhsc.edu, Yeo, Suyeon2 (AUTHOR) |
| Source: | Clinical Drug Investigation. Oct2020, Vol. 40 Issue 10, p901-913. |
| Database: | SPORTDiscus with Full Text |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
